ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

STXS Stereotaxis Inc

2.32
-0.09 (-3.73%)
02 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Stereotaxis Inc STXS AMEX Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.09 -3.73% 2.32 18:21:58
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
2.41 2.30 2.41 2.32 2.41
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
22/4/202406:51GLOBEStereotaxis to Report First Quarter 2024 Financial Results..
08/3/202414:21EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
04/3/202415:06EDGAR2Form 8-K - Current report
04/3/202415:06GLOBEStereotaxis Announces Regulatory Submissions of the MAGiC..
04/3/202415:05GLOBEStereotaxis Reports 2023 Full Year Financial Results
22/2/202415:15GLOBEIntermountain Health Extends Leadership in Heart Care with..
20/2/202408:05GLOBEStereotaxis to Report Fourth Quarter and Full Year 2023..
14/2/202415:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/1/202407:34GLOBEStereotaxis Announces First Patients Successfully Treated..
02/1/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202307:42GLOBEBaptist Health Lexington Enhances 20-Year Leadership in..
20/11/202307:54GLOBEStereotaxis to Participate in Piper Sandler 35th Annual..
13/11/202308:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202308:05EDGAR2Form 8-K - Current report
09/11/202308:00GLOBEStereotaxis Reports 2023 Third Quarter Financial Results
31/10/202307:57GLOBEAbbott and Stereotaxis Technologies Used in First Integrated..
17/10/202308:05GLOBEStereotaxis to Report Third Quarter 2023 Financial Results..
04/10/202307:49GLOBEStereotaxis Robotic Technology to be Featured during 7th..
06/9/202307:56GLOBEHeart Centre Rigshospitalet Enhances Leadership in Patient..
30/8/202307:49GLOBEOverland Park Regional Medical Center Becomes First U.S...
16/8/202307:40GLOBELive Long-Distance TeleRobotic Procedures to Highlight..
11/8/202308:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202308:05EDGAR2Form 8-K - Current report
10/8/202308:00GLOBEStereotaxis Reports 2023 Second Quarter Financial Results
18/7/202308:18GLOBEStereotaxis and Abbott Combine Technologies in First..
17/7/202305:00GLOBEStereotaxis to Report Second Quarter 2023 Financial Results..
03/7/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/7/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/7/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/7/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/7/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/6/202315:10GLOBEStereotaxis to Initiate First-in-Human Trial to Support CE..
25/5/202307:56GLOBEStereotaxis to Participate in 20th Annual Craig-Hallum..
23/5/202307:46GLOBEAdvocate Christ Medical Center Extends Leadership in Heart..
19/5/202307:38GLOBEStereotaxis and Abbott Announce Global Collaboration..
09/5/202308:00GLOBEStereotaxis Reports 2023 First Quarter Financial Results

Su Consulta Reciente

Delayed Upgrade Clock